These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of cyclosporine with poor initial renal function results in severely diminished renal clearance up to three years following liver transplantation. Cooper JL; Wahlstrom E; Anderson J; Schwerman L; Poterucha J; Krom RA Transplant Proc; 1991 Feb; 23(1 Pt 2):1489-91. PubMed ID: 1989274 [No Abstract] [Full Text] [Related]
10. Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients. Gupta SK; Legg B; Solomon LR; Johnson RW; Rowland M Br J Clin Pharmacol; 1987 Oct; 24(4):519-26. PubMed ID: 3318898 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine pharmacokinetics in the early course of renal transplantation. Albrecht K; Niebel W; Marggraf G; Eigler FW Transplant Proc; 1987 Feb; 19(1 Pt 2):1719. PubMed ID: 3274413 [No Abstract] [Full Text] [Related]
12. Improved immunosuppression for heart transplantation. Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of oral ciclosporin in the perioperative period after heart transplantation. Konertz W; Leimenstoll G; Weyand M; Friedl A; Bernhard A Bibl Cardiol; 1988; (43):42-5. PubMed ID: 3067722 [No Abstract] [Full Text] [Related]
14. Cyclosporine A-related nephrotoxicity after cardiac transplantation: the role of plasma renin activity. Schüler S; Thomas D; Hetzer R Transplant Proc; 1987 Oct; 19(5):3998-4001. PubMed ID: 3313982 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patients. Gupta SK; Bakran A; Johnson RW; Rowland M Br J Clin Pharmacol; 1989 Mar; 27(3):353-7. PubMed ID: 2655684 [TBL] [Abstract][Full Text] [Related]
16. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients. Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380 [TBL] [Abstract][Full Text] [Related]
17. Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period. Awni WM; Kasiske B; Heim-Duthoy K; Rose M; Rao VK; Bloom P; Ney A; Andrisevic J; Odland M; Andersen RC Transplant Proc; 1988 Apr; 20(2 Suppl 2):623-4. PubMed ID: 3284111 [No Abstract] [Full Text] [Related]
18. Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio. Oldhafer KJ; Schumann G; Wonigeit K; Oellerich M; Ringe B; Pichlmayr R Transplant Proc; 1988 Jun; 20(3 Suppl 3):361-5. PubMed ID: 3291268 [No Abstract] [Full Text] [Related]
19. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation]. Morales J; Mocarquer A; James E; Aris L; Herrera L; Morales I Rev Med Chil; 1987 Dec; 115(12):1172-5. PubMed ID: 3332925 [No Abstract] [Full Text] [Related]